Background
Occurrence of gastric ulcer has been associated with numerous factors such as imbalance between protective and aggressive factors, pulmonary and liver diseases, alcohol consumption, and non-steroidal and steroidal drugs [
1,
2]. Due to favorable preventive effects in instances of malignant tumors, eclampsia, dementia, and hyperlipidemia, the demand for non-steroidal anti-inflammatory drugs (NSAIDs) has remarkably increased in recent years [
3]. However, NSAIDs have also been linked with risks of adverse gastrointestinal disorders including gastric mucosal ulceration, erosion, bleeding, and perforation [
4]. About 25% of urgent gastric ulcers have been related to NSAIDs administration [
5], with various factors like stress and
Helicobacter pylori infections exacerbating the condition related to gastric ulcers [
6].
Various synthetic anti-ulcer drugs such as misoprostol are used to cure NSAID induced gastric ulcers. Similarly, indomethacin (IND) is widely approved in medical practice as being an NSAID; it shows exceptional efficiency in the treatment of fever, pain and inflammation by suppressing the synthesis of prostaglandins through inhibiting the cyclooxygenase enzymes [
7]. However, NSAIDs such as IND administration result in gastrointestinal tract infections due to the inhibition of prostaglandin synthesis [
8]. In addition, IND generates harmful reactive oxygen species (ROS) involved in pathogenesis of gastric ulcers [
9]. Apparently, the free radical scavenging property of synthetic drugs might have a protecting effect against gastric mucosal oxidative damage that accelerates healing of gastric ulcers [
10]. However, disorder of gastric mucosal antioxidant defense system has also been associated with NSAIDs [
11].
Investigating dietary plants that are valued in traditional medicine might hold promise for prolonged use. Functional foods originating from natural sources are gaining significance in the pharmaceutical industry. Fermented herb extracts have been widely used as a source of bioactive compounds in pharmaceutical and food industries as bioactivity of natural herbs increases during fermentation through biotransformation or probiotic effect [
12‐
14]. Fermented barley extracts have revealed effective pharmacological effects including antioxidant [
15], anti-atopic dermatitis [
16], uric acid lowering [
17], hepatoprotective [
15], and immunostimulatory [
18] activities. Potent anti-ulcer agents from natural herbs with strong antioxidant effects, such as
Artemisia asiatica extract (Stillen™, Dong-A Pharmaceuticals, Yongin, Rep. of Korea) have also appeared in the market [
19].
It is noted that fermented barley extract shows potent antioxidant potential in various in vivo models [
20,
21], and indomethacin induces gastric ulcer in Sprague-Dawley animal models [
6,
10]. This gained our attention to address the possible protective effect of fermented barley against IND-induced gastric ulcers in Sprague-Dawley rat model. Previously, we reported triple fermentation of barley using saccharification with
Weissella and
Saccharomyces as an effective and valuable fermentation choice [
22‐
24] with less toxicity [
25], and the present research intended to estimate the healing effect of triple fermented barley extract (FBe) on the IND-induced gastric ulcers in Sprague-Dawley rats, a representative valuable animal model to screen for gastroprotective agents [
6,
10].
Discussion
Mucosal damages can be easily generated by exogenous and endogenous ROS and free radicals [
38]. Changes in the gastric mucosal antioxidant defense system have been linked with the pathogenesis and progression of NSAIDs associated gastric ulcers [
11]. Indomethacin, an NSAID, is widely approved in medical practice [
7]; however, an ulcerative gastrointestinal effect may arise from the inhibition of prostaglandin synthesis [
8] and harmful ROS generations [
38]. The antioxidants are advocated to offer effective protection against induction and progression of gastric ulcers [
39,
40], and the fermentation processes are linked with increased bioavailability of various phenolic compounds and antioxidants [
15,
41,
16‐
18]. The reported medicinal attributes and antioxidant properties of the natural substances prompted our assessment of the possible protective effects of FBe against IND-induced gastric lesions in Sprague-Dawley rat model.
The decrease in the gross hemorrhagic lesion area was considered as an indicator of the protective effects of the test substances on the gastric mucosa corroborating previous efficacy studies [
28,
42]. Lesser gross lesions are equal to more favorable protective effects [
10]. FBe (200 mg kg
− 1) inhibited the gastric gross lesion areas and showed similar gastroprotective effects as those observed with OM (10 mg kg
− 1) in IND-induced gastric mucosal damaged rats. This suggests that FBe dosage can be effectively regulated for patients undergoing various gastric disorders, starting with a dose of 100 mg kg
− 1.
IND markedly enhanced the MPO activity in stomach tissue whereas all three doses of FBe significantly lowered the MPO activity. FBe (200 mg kg
− 1) displayed inhibitory effect on the increase of IND-induced MPO activities similar to those observed on treatments with OM. An increase in MPO activity has been reported in NSAID-damaged stomach tissue [
40], which shows increased neutrophil secretion in stomach lesions [
43]. Excessive secretions of free radicals such as OH, H
2O
2, and O
2 due to the neutrophil secretion cause tissue damages [
43]. Therefore, the dose-dependent decreases in MPO activity after a single oral administration of FBe demonstrate that FBe has favorable anti-inflammatory effects, and can suppress the harmful effects of infiltrated neutrophils in gastric mucosa induced by IND treatment.
All tested doses of FBe markedly lowered the lipid peroxidation (MDA content) compared to the IND control. FBe (200 mg kg
− 1) also decreased the MDA level in a similar manner as OM. The increase in MDA level is associated with increased tissue damage and it is an important cause of gastric damages associated with NSAIDs [
44,
45].
GSH and other antioxidant mechanisms regulate the ROS at a specific required cellular concentration which prevents tissue damage [
46]. The GSH levels in the stomach tissue of FBe (200 mg kg
− 1) -administered rats were statistically higher compared to those observed in the IND control rats. Especially, higher GSH levels were observed in the stomach tissues with less damage. This increase in GSH levels is associated with gastroprotective effects of FBe and illustrates that the FBe dosage can be easily regulated for patients suffering from different levels of gastric damages.
Statistically different CAT activity was observed in stomach tissue of the healthy rats and the IND control rats. CAT activity in the FBe (200 mg kg
− 1) -administered rats decreased significantly in a dose-dependent manner. Previous studies have shown an increasing trend in CAT activity in the IND-induced stomach damages [
47,
48]. The increased CAT activity in IND-administered groups shows an increase in H
2O
2 while the decreased CAT activity in FBe-administered groups indicates a decreased oxidative stress.
The outcomes of this study support earlier studies stating that NSAIDs lower SOD activity in rat stomach tissues [
47,
48]. SOD activity was inhibited in IND-administered rats; however, FBe and OM showed higher SOD activity. FBe (200 mg kg
− 1) showed an inhibitory effect against IND-induced SOD activity inhibition similar to those observed on treatment with OM. SOD and other antioxidants are important in reducing IND-induced gastric damage as it partially prevents oxidative damages [
49]. The relationship between prostaglandin synthesis and SOD activity has been studied in details and it is considered as a possible mechanism of IND-induced ulcers [
46,
49].
Gastric mucosal histopathological analysis revealed enhanced focal extensive desquamation of focal epithelium superficial epithelial damage, focal hemorrhages/congestions, neutrophil necrosis and infiltrations of gastric glands, and ulcerative lesions. The findings of this study were similar to the previously reported studies of Bhattacharya et al. [
6], and Graziani et al. [
50]. Histopathological analysis has been used as a valuable criterion to estimate the gastroprotective effects of new medicinal products, including herbal extracts [
10,
51,
52]. In the present study, OM and FBe significantly inhibited the IND associated microscopic ulcerative lesions in a dose-dependent manner. FBe (200 mg kg
− 1) exhibited a histopathological effect similar to that observed in treatment with OM. The changes were re-confirmed by histomorphometric analysis. Peri-ulcerative mucosal thickness was significantly decreased while the percentage of invaded lesions and the semiquantitative histological scores were prominently increased in IND treatment group. However, the changes were favorably normalized in a dose-dependent manner with FBe and after a single oral application of OM. The changes observed in OM treatment were similar to those observed in treatment with FBe (200 mg kg
− 1).
The acute toxicity profile of the test material (FBe), analyzed in a previous study by our group [
21], showed non-toxic behavior of FBe to mice, and therefore, it was considered likely to be safe for medical use. A single oral application of FBe showed an LD
50 of > 2000 mg kg
− 1, which is the KFDA (Korean Food and Drug Administration) recommended dose for both male and female rodents. FBe in this study showed a significant and dose-dependent decrease in IND-induced gastric damage, the hemorrhagic gross lesion, gastric MPO content, and histopathological gastric ulcerative lesion. Additionally, FBe dose-dependently strengthened the antioxidant defense systems, lowered lipid peroxidation level, and CAT activity but enhanced the SOD activity and GSH content. Similar results were obtained in our previous study on the gastroprotective effect of FBe on HCl/Et-OH-induced gastric mucosal damage in mice [
53]. FBe (200 mg kg
− 1) showed promising gastroprotective effects in the present study on indomethacin-induced gastric ulcer in rats and in the previous study on HCl/Et-OH-induced gastric ulcer in mice [
53]. The inhibitory effects were similar to the commercially available anti-ulcer drugs, such as ranitidine (100 mg kg
− 1) and omeprazole (10 mg kg
− 1). In our previously study, FBe (200 and 300 mg kg
− 1) also indicated satisfactory laxative effects, mediated by the increase in gastrointestinal motility in normal rats [
20]. Hence, FBe, as a potent food supplement, can be suitable for patients suffering from gastric mucosal disorders.
The findings of this study are considered as direct evidence that oral administration of FBe had promising gastroprotective effects by strengthening the anti-inflammatory effects and the innate antioxidant defense system. It has been reported that the polyphenols and total flavonoids have potent antioxidant and anti-inflammatory effects. Thus, the total polyphenols and flavonoids contents of FBe may be responsible for the anti-inflammatory, antioxidant, and gastroprotective effects of FBe. Further research is needed to elucidate the specific polyphenols and flavonoids responsible for its antioxidant and anti-inflammatory effects.